Dinicolantonio J. Aspirin 50 versus 100 mg: a case of wrong dosing. Am J Cardiol. 2011;108:1840 pubmed publisher
Dinicolantonio J, Hackam D. Carvedilol: a third-generation ?-blocker should be a first-choice ?-blocker. Expert Rev Cardiovasc Ther. 2012;10:13-25 pubmed publisher
..We will provide compelling evidence of why carvedilol should be a first-line ?-blocker and why it offers many advantages over the ?1-selective ?-blockers...
Dinicolantonio J. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365:2235; author reply 2236 pubmed publisher
Dinicolantonio J, Lucan S, O Keefe J. The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. Prog Cardiovasc Dis. 2016;58:464-72 pubmed publisher
Dinicolantonio J, Chatterjee S, O Keefe J. Dietary Salt Restriction in Heart Failure: Where Is the Evidence?. Prog Cardiovasc Dis. 2016;58:401-6 pubmed publisher
..To evaluate the strength of current evidences to recommend dietary salt restriction among HF patients, we performed a comprehensive literature review and explored the safety and efficacy of such recommendations. ..
Dinicolantonio J, O Keefe J. Hypertension Due to Toxic White Crystals in the Diet: Should We Blame Salt or Sugar?. Prog Cardiovasc Dis. 2016;59:219-225 pubmed publisher
..Based on our review of the scientific literature, guidelines should focus more on reducing sugar rather than salt for the prevention and treatment of HTN and its consequences. ..
McCarty M, DiNicolantonio J. Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases. Healthcare (Basel). 2016;4: pubmed publisher
..Ingestion of omega-3-rich flaxseed or fish oil may also have potential for controlling osteolysis in cancer patients. ..
Dinicolantonio J, Liu J, O Keefe J. Thiamine and Cardiovascular Disease: A Literature Review. Prog Cardiovasc Dis. 2018;: pubmed publisher
Dinicolantonio J, Lavie C, Fares H, Menezes A, O Keefe J. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol). Am J Cardiol. 2013;111:765-9 pubmed publisher
..Additionally, carvedilol significantly reduced all-cause mortality compared with ?(1)-selective BBs in AMI patients using the fixed-effects model but not using the random-effects model...